🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Ubenimex is being developed for the treatment of pulmonary arterial hyperte...
Status
Terminated
Location
California Heart Center Foundation, An Affiliate of Cedars-Sinai Heart Institute, Cedars-Sinai Medical Care Foundation
Start Date
2016-12
Trial ID
NCT02736149
Treatments Being Tested
Researchers want to find out if a drug called Cipro® XR (ciprofloxacin exte...
Status
Completed
Location
Multiple Locations
Start Date
2004-05
Trial ID
NCT00481689
Treatments Being Tested
This is a 1-year, open-label, long-term safety extension for patients who h...
Status
Completed
Location
Kyowa Pharmaceutical Inc.
Start Date
2004-10
Trial ID
NCT00199368
Treatments Being Tested
A phase II, open-label, multicenter, randomized controlled trial exploring ...
Status
Not Yet Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-09
Trial ID
NCT07150208
Treatments Being Tested
This study will evaluate the long-term safety, efficacy and tolerability of...
Status
Completed
Location
Takanoko Hospital /ID# 232723
Start Date
2020-06-18
Trial ID
NCT04437433
Treatments Being Tested
To assess the efficacy of intravitreal (IVT) administration of aflibercept ...
Status
Completed
Location
Multiple Locations
Start Date
2014-12-19
Trial ID
NCT02305238
Treatments Being Tested
This is a Phase II/III, randomized, double-blind, placebo-controlled, multi...
Status
Completed
Location
Stanford University Medical Center
Start Date
2017-12-08
Trial ID
NCT03231878
The purpose of this long term extension study is to assess safety, tolerabi...
Status
Terminated
Location
Meitetsu Hospital
Start Date
2010-12
Trial ID
NCT01238991
This study will evaluate the efficacy and safety of mosunetuzumab in combin...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2021-10-27
Trial ID
NCT04712097
Treatments Being Tested
The purpose of this six-month treatment study is * to assess feasibility o...
Status
Completed
Location
Alabama Clinical Therapeutics, LLC
Start Date
2018-09-18
Trial ID
NCT04467697
Treatments Being Tested